The Effectiveness of Complex Use of Inosine Pranobex and Recombinant Interferon
| Autor: | A. V. Grigoryan, V. B. Denisenko, E. N. Simovanyan |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2015 |
| Předmět: |
frequently ill children
Pediatrics Virus RJ1-570 Serology law.invention chemistry.chemical_compound Immune system law Inosine pranobex Medicine IL-2 receptor clamidiosis CD20 recombinant interferon-a2b biology business.industry General Engineering chronic epstein-barr virus infection chemistry inosine pranobex Immunology Recombinant DNA biology.protein business CD8 |
| Zdroj: | Detskie Infekcii (Moskva), Vol 14, Iss 4, Pp 31-45 (2015) |
| ISSN: | 2072-8107 |
| Popis: | The purpose of research — improvement of treatment programs for chronic Epstein-Barr virus mono-infection and mixed with clamidiosis infection in frequently ill children with use of inosine pranobex (isoprinosine) and recombinant interferon-a2b (viferon). Clinical, serological and immunological examination of 116 patients aged from 3 to 6 years with chronic Epstein-Barr virus infection in the form of mono-infection (48) and mixed with clamidiosis infection (68) is conducted. In the complex therapy of 24 children with mono-infection and 42 patients with mixed infection, inosine pranobex in combination with recombinant interferon-a2b were included. In 24 patients with mono-infection and 26 children with mixed infection, using only recombinant interferon-a2b. In patients with monoinfection, multiorgan pathology (respiratory, lymphoproliferative, cardial, cerebral, arthralgiс syndromes) was found. During serological examination found markers of active Epstein-Barr virus infection (IgM to VСA, IgG to EA, a high level of IgG to EBNA). Changes of the immune status was associated with activation of immune system (increase of CD8, HLA-DR, CD16, IgA, IgM, IgG, metabolic activity of neutrophils) and its damage (reduction of CD3, CD4, CD25, CD20, interferon-a, interleukin-4, reserve possibilities of neutrophils metabolism, increase of CD95, circulating immune complexes). Development of mixed infection led to a deepening of immunological disorders and increased frequency of respiratory, gastrointestinal and lymphoproliferative syndromes. When combined inosine pranobex and recombinant interferon-a2b was going to potentiation antiviral, of immunomodulatory and cytoprotective activity of drugs that reduced the incidence of acute respiratory infections and severity of multiorgan pathology. High efficiency and safety of inosine pranobex and recombinant interferon-a2b combination allow to recommend its inclusion in the complex therapy of patients from frequently ill children group with various forms of chronic Epstein-Barr virus infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|